Navigation Links
Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
Date:1/10/2013

ations for two weeks during the quarter for the Thanksgiving, Christmas and New Year holidays as part of our cost reduction program.  Our backlog is strong for the second half of fiscal 2013.  We expect to continue to press down on our cost structure while increasing engineering resources.  We expect the programs and projects that we have begun to move our company forward and to build value for every shareholder."

"Of course," Mr. Berthelot noted, "we appreciate the support of each and every shareholder as we pursue our strategy amidst the distraction and diversion of resources due to the contested election of directors.  We understand that there have been some logistical problems in our proxy materials arriving to our shareholders on the West Coast.  If you have not yet received the Company's proxy materials which include the BLUE proxy card, we encourage you to contact our proxy solicitor, AST Phoenix Advisers, at 1-866-721-1318 and ask for the materials to be sent to you.  We ask that all of our shareholders vote for the Pro-Dex director nominees using the BLUE proxy card as quickly as possible, and we thank you for your support."

Teleconference Information:Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2013 second quarter and six-month financial results today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Ea
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
2. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
6. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
7. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
8. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
9. Accelr8 Announces Results of 2012 Annual Meeting
10. OncoSec Medical Announces $7.2 Million Public Offering
11. Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... ), today announced the publication of Phase III PROCHIEVE® ... Ultrasound in Obstetrics & Gynecology , the leading peer-reviewed ... & Gynecology. The published results indicate ...
... SAN DIEGO, April 6, 2011 ... a leading global medical technology company, today announced ... of pharmaceutical waste, helping hospitals reduce cost, improve ... (Photo:   http://photos.prnewswire.com/prnh/20110406/LA78173 ) (Logo:   ...
Cached Medicine Technology:Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 2Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 3Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 4Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 5Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 6Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 7Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 8CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 2CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 3
(Date:4/22/2014)... 22 April 2014. The latest scientific advances and emerging ... Failure 2014, the main annual meeting of the Heart ... (ESC). Journalists will also hear breaking news on acute ... Heart Failure, which is part of the main congress. ... Athens, Greece, at the Megaron Athens International Conference Centre ...
(Date:4/22/2014)... have demonstrated the first size-based form of chromatography ... of living cells. This unique physical approach to ... to whether a cell lives or dies, remains ... through conventional microscopy. , "We,ve developed membrane-embedded nanodot ... both probe and manipulate membrane assemblies, including signaling ...
(Date:4/22/2014)... exposed to trauma, illness, alcohol or other drug abuse, ... brain cells that can go awry and activate conditions ... of autism. , Until now, it has been unclear ... a developing brain. Past studies have shown that when ... abuse or she experiences some trauma or illness, her ...
(Date:4/22/2014)... fiction: In enemy territory, activate your cloaking device. And ... to the immune system. Now scientists at Harvard,s Wyss ... tactics to build the first DNA nanodevices that survive ... the way for smart DNA nanorobots that could use ... doctors can today; target drugs to tumors, or even ...
(Date:4/22/2014)... can help doctors better identify patients who are at ... prevent the often deadly condition, suggest data from a ... Anesthesiology . , Affecting nearly 200,000 Americans a ... failure of the lungs caused by a number of ... infection. High-risk patients can develop ARDS after surgery. ARDS ...
Breaking Medicine News(10 mins):Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2
... ... Victory: Cortical Concepts Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device ... with Private Sales for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The ...
... ... of Science and Technology Policy, will bring together leaders in open innovation , ... Washington, DC (Vocus) -- ... Open Grant Making”, a public-private strategy session jointly hosted by the White House Office ...
... team of researchers at the University of Georgia and Emory ... from the National Institutes of Health to study the neurobiological ... relapse. "Drug abuse is closely linked to stress, ... is preventing the relapse caused by stress," said Philip Holmes, ...
... ... grant from the Ontario Ministry of Research and Innovation’s Biopharmaceutical Investment Program (BIP). ... facility in Mississauga, Ontario, Canada. , ... Toronto, ON (Vocus) April 30, 2010 -- Therapure Biopharma Inc. ...
... mutation impacts how the brain communicates with limbs, researcher says ... that causes a phenomenon known as mirror movements has been ... unable to move one side of their body without moving ... right hand, the same movement occurs unintentionally in the left ...
... ... Association, a non-profit organization, has developed a unique caregiver testing program to measure the ... and consumers. , ... Indianapolis, Ind. (Vocus) April 29, 2010 -- The National Private Duty Association (NPDA), a ...
Cached Medicine News:Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:Prize4Life Featured in Major Innovation/Prize National Conference 2Health News:Prize4Life Featured in Major Innovation/Prize National Conference 3Health News:UGA, Emory to study how exercise may prevent drug abuse relapse 2Health News:Therapure Awarded $4.2 Million BIP Grant from the Ontario Government 2Health News:Scientists Find Cause of Involuntary Mirror Movements 2Health News:Association Advocates Testing for Home Care Workers 2
30 cm - 11 3/4, packages 5 pcs....
Outer diameter 8.0 mm, with graduation....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Length-9 (229 mm) Tapered retractor blades....
Medicine Products: